Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 31

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 31
---
 or aspect of the Divestiture Agreement or the Divestiture and does not constitute a recommendation to any stockholder of Aadi as to whether or how such holder should vote with respect to the Divestiture or otherwise act with respect to the Divestiture or any other matter.

The full text of the written opinion of Leerink Partners should be read carefully in its entirety for a description of the assumptions made and qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion.

The Divestiture Agreement (see page 73)

Per the terms and subject to the conditions of the Divestiture Agreement, Kaken will pay Aadi $100 million
in cash at closing, subject to certain purchase price adjustments, in exchange for 100% of the outstanding shares of capital stock of Aadi Sub and thereby all or substantially all of Aadi’s assets related to the FYARRO Business.

- 20 -

The transaction is expected to close in the first half of 2025, subject to Aadi stockholder approval and certain closing conditions. Upon the closing of this transaction, Kaken will also acquire the rights to the Aadi name and trademark. Conditions to the Completion of the Divestiture(see page 91) The respective obligations of Kaken, Aadi and Aadi Sub, as applicable, to complete the Divestiture are subject to the satisfaction or waiver (where permitted by applicable law), at or prior to the completion of the Divestiture of certain conditions, including the following:

| • |     | the approval of the Divestiture Agreement and the Divestiture by the requisite affirmative vote of Aadi 
 stockholders at the Special Meeting;                                                                    |

| • |     | the receipt of all consents and approvals (if any) required under any regulatory laws applicable to the 
 Divestiture;                                                                                            |

| • |     | the absence of any of the following, that, in each case, prevents or materially impairs the completion of the 
 Divestiture:                                                                                                  |

| • |     | any temporary restraining order, preliminary or permanent injunction or other judgment or order issued by any 
 court of competent jurisdiction;                                                                              |

| • |     | legal or regulatory restraint or prohibition by any governmental authority of competent jurisdiction; and |

| • |     | any law enacted, entered, enforced or applied to the Divestiture. |

In addition, the obligations of Kaken to complete the Divestiture are subject to the satisfaction or waiver (where permitted by applicable law) at